Clinical trial
Citalopram in Treating Postmenopausal Women With Hot Flashes
NCT00363909 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00363909 |
|---|---|
| Title | Citalopram in Treating Postmenopausal Women With Hot Flashes |
| Official title | Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment |
| Intervention type | Drug, Other |
| Interventions | citalopram hydrobromide, placebo |
| Enrollment | 254 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Dec 1, 2010 |
| First posted | Aug 15, 2006 |
| Last update posted | Dec 13, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: